Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2012 3
2014 7
2015 2
2016 8
2017 2
2018 6
2019 9
2020 16
2021 17
2022 18
2023 23
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean zhi hao lu (21 results)?
Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-γ signaling in squamous cancer.
Jiang Y, Zheng Y, Zhang YW, Kong S, Dong J, Wang F, Ziman B, Gery S, Hao JJ, Zhou D, Zhou J, Ho AS, Sinha UK, Chen J, Zhang S, Yin C, Wei DD, Hazawa M, Pan H, Lu Z, Wei WQ, Wang MR, Koeffler HP, Lin DC, Jiang YY. Jiang Y, et al. Among authors: lu z. Nat Commun. 2024 Mar 20;15(1):2484. doi: 10.1038/s41467-024-46785-9. Nat Commun. 2024. PMID: 38509096 Free PMC article.
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas.
Zhang J, Chen H, Zhang J, Wang S, Guan Y, Gu W, Li J, Zhang X, Li J, Wang X, Lu Z, Zhou J, Peng Z, Sun Y, Shao Y, Shen L, Zhuo M, Lu M. Zhang J, et al. Among authors: lu z. Chin J Cancer Res. 2024 Feb 29;36(1):90-102. doi: 10.21147/j.issn.1000-9604.2024.01.09. Chin J Cancer Res. 2024. PMID: 38455367 Free PMC article.
Helicobacter pylori and immunotherapy for gastrointestinal cancer.
Jia K, Chen Y, Xie Y, Wang X, Hu Y, Sun Y, Cao Y, Zhang L, Wang Y, Wang Z, Lu Z, Li J, Zhang X, Shen L. Jia K, et al. Among authors: lu z. Innovation (Camb). 2024 Jan 8;5(2):100561. doi: 10.1016/j.xinn.2023.100561. eCollection 2024 Mar 4. Innovation (Camb). 2024. PMID: 38379784 Free PMC article.
Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial.
Wang Y, Gong J, Wang A, Wei J, Peng Z, Wang X, Zhou J, Qi C, Liu D, Li J, Lu M, Lu Z, Cao Y, Yuan J, Zhang R, Fang J, Zhang X, Shen L. Wang Y, et al. Among authors: lu z. EClinicalMedicine. 2024 Jan 5;68:102415. doi: 10.1016/j.eclinm.2023.102415. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38235421 Free PMC article.
Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy.
Cheng S, Han Z, Dai D, Li F, Zhang X, Lu M, Lu Z, Wang X, Zhou J, Li J, Guo X, Song P, Qiu C, Shen W, Zhang Q, Zhu N, Wang X, Tan Y, Kou Y, Yin X, Shen L, Peng Z. Cheng S, et al. Among authors: lu z. Cell Rep Med. 2024 Jan 16;5(1):101355. doi: 10.1016/j.xcrm.2023.101355. Epub 2024 Jan 8. Cell Rep Med. 2024. PMID: 38194971 Free PMC article.
The landscape of cancer research and cancer care in China.
Lu Z, Chen Y, Liu D, Jiao X, Liu C, Wang Y, Zhang Z, Jia K, Gong J, Yang Z, Shen L. Lu Z, et al. Nat Med. 2023 Dec;29(12):3022-3032. doi: 10.1038/s41591-023-02655-3. Epub 2023 Dec 12. Nat Med. 2023. PMID: 38087112 Review.
112 results